15-31327301-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015995.4(KLF13):c.89G>A(p.Gly30Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000222 in 1,304,284 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015995.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 149966Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000882 AC: 1AN: 11342Hom.: 0 AF XY: 0.000134 AC XY: 1AN XY: 7436
GnomAD4 exome AF: 0.0000234 AC: 27AN: 1154318Hom.: 0 Cov.: 33 AF XY: 0.0000320 AC XY: 18AN XY: 562692
GnomAD4 genome AF: 0.0000133 AC: 2AN: 149966Hom.: 0 Cov.: 33 AF XY: 0.0000273 AC XY: 2AN XY: 73162
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2023 | The c.89G>A (p.G30E) alteration is located in exon 1 (coding exon 1) of the KLF13 gene. This alteration results from a G to A substitution at nucleotide position 89, causing the glycine (G) at amino acid position 30 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at